Bam

[anonymous]

The only way this mess is cleaned up is with Rick stepping aside. He led this org to this mess. These are his leaders. This is his RDLT that produces nothing. This company can’t even get an old drug in a simple device approved. Has there been any consequence to the accountable leaders? Any leader with any real drug development experience and self respect has left. You have the consultant, the scientist and the misfits left. Nothing will be produced by this team.

As for commercial, it’s impossible not to sell with the 24/7 DTC AbbVie pays for. What pays for that are the drugs - almost all acquired and not discovered by AbbVie.

The strategy group knew (past tense) what it was doing most importantly in business development. What remains of it are the the light weight blowhards.

And who’s to blame when the issues are so broad other than the chief executive. Time to go.

Ironically Abbvie’s first attempted approval also resulted in a CRL: duadopa

Other companies mock our relentless DTC. It’s what sponsors with a limited pipeline do.

 

[anonymous]

And there you go losers!!!